scholarly journals Pectin inhibits invasiveness of breast and prostate cancer cells by down‐regulation of urokinase plasminogen activator (uPA) secretion

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Rachael Wojnowski ◽  
Jiahua Jiang ◽  
Andrej Jedinak ◽  
Daniel Sliva
Keyword(s):  
Prostate Cancer ◽  
Cancer Cells ◽  
Plasminogen Activator ◽  
Urokinase Plasminogen Activator ◽  
Prostate Cancer Cells ◽  
Down Regulation ◽  
Breast And Prostate Cancer

NFκB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells

2010 ◽  
Vol 21 (6) ◽  
pp. 528-533 ◽  
Author(s):  
Ryoji Uchino ◽  
Radha Madhyastha ◽  
Harishkumar Madhyastha ◽  
Sandra Dhungana ◽  
Yuichi Nakajima ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Cells ◽  
Plasminogen Activator ◽  
Grape Seed Extract ◽  
Urokinase Plasminogen Activator ◽  
Grape Seed ◽  
Seed Extract ◽  
Prostate Cancer Cells

scholarly journals Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells

Nutrients ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 488 ◽  
Author(s):  
Yeong-Seon Won ◽  
Kwon-Il Seo
Keyword(s):  
Prostate Cancer ◽  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Cancer Cells ◽  
Mtor Signaling ◽  
Human Prostate ◽  
Human Prostate Cancer ◽  
Prostate Cancer Cells ◽  
Down Regulation ◽  
Cycle Arrest

Prostate cancer is the most common cancer in Western countries. Recently, Asian countries are being affected by Western habits, which have had an important role in the rapid increase in cancer incidence. Sanggenol L (San L) is a natural flavonoid present in the root barks of Morus alba, which induces anti-cancer activities in ovarian cancer cells. However, the molecular and cellular mechanisms of the effects of sanggenol L on human prostate cancer cells have not been elucidated. In this study, we investigated whether sanggenol L exerts anti-cancer activity in human prostate cancer cells via apoptosis and cell cycle arrest. Sanggenol L induced caspase-dependent apoptosis (up-regulation of PARP and Bax or down-regulation of procaspase-3, -8, -9, Bid, and Bcl-2), induction of caspase-independent apoptosis (up-regulation of AIF and Endo G on cytosol), suppression of cell cycle (down-regulation of CDK1/2, CDK4, CDK6, cyclin D1, cyclin E, cyclin A, and cyclin B1 or up-regulation of p53 and p21), and inhibition of PI3K/Akt/mTOR signaling (down-regulation of PI3K, p-Akt, and p-mTOR) in prostate cancer cells. These results suggest the induction of apoptosis via suppression of PI3K/Akt/mTOR signaling and cell cycle arrest via activation of p53 in response to sanggenol L in prostate cancer cells.

Sign in / Sign up

Export Citation Format

Share Document